Aquestive Therapeutics Announces Closing of Initial Public Offering

WARREN, N.J., July 27, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and commercializing differentiated products to address unmet medical needs, today announced the closing of its initial public offering of...